Page last updated: 2024-10-29

iopromide and Leukemia

iopromide has been researched along with Leukemia in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hilmes, MA1
Dillman, JR1
Mody, RJ1
Strouse, PJ1

Other Studies

1 other study available for iopromide and Leukemia

ArticleYear
Pediatric renal leukemia: spectrum of CT imaging findings.
    Pediatric radiology, 2008, Volume: 38, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Iohexol; Kidney Neoplas

2008